~~<i id='523FE3325D'><strike id='523FE3325D'><tt id='523FE3325D'><pre id='523FE3325D'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

fashion

author：comprehensive 2025-08-11 16:24:17 - browse：78

Alkermes shareholders voted Thursday to re-elect all of the drugmaker’s current directors, ending an acrimonious proxy fight with hedge fund Sarissa Capital Management, which had sought to seat three directors on the board.

At the company’s annual meeting, shareholders voted in favor of Alkermes’ proposal to retain all seven of the director nominees to the 11-person board.

The outcome is a setback for Sarissa, which owns 8.5% of Alkermes and is run by activist investor Alex Denner. Sarissa has accused Alkermes executives of mismanaging the business and destroying shareholder value.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Biotech execs pursue obesity drug boom: ‘It’s the early innings’

Wikipedia

entertainment

Wikipedia

knowledge

leisure time

Sen.BernieSandershasusedhisleadershipofaSenatecommitteetopressuredrugmakerstolowertheirprices.KevinD

WSS

Illumina names Agilent executive as new CEO

Snackable artificial intelligence, expert AI, and the pharma industry

AltruBio raises $225 million to develop ulcerative colitis drug

Novel spinal cord stimulator treats paralysis without surgery

Welsh Carson private equity firm escapes from FTC antitrust case

Black vets could get higher VA benefits if race not used in lung test

knowledge

fashion

Wikipedia

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

How a small hospital in rural Puerto Rico survived Hurricane Maria

23andMe had bad news about my health. I wish a person had delivered it

The 10 drugs up first for Medicare price negotiation

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Amazon on where the company's health care bets are headed next

Supreme Court strikes down use of affirmative action

Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

Trump demands the U.S. pay no more for drugs than other countries … again

Illumina names Agilent executive as new CEO

entertainment

'Make People Better': The CRISPR babies story you probably don't know

Stem cell treatment guidelines are released by FDA

Amazon on where the company's health care bets are headed next

Deliver public health messages at the right time

How generative AI is inspiring dreams of a health data revolution

Weighted lottery helped low

entertainment

Wikipedia

knowledge

leisure time